Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 8/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | POLB | P06746 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26834642 | 0.90 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL26834970 | 0.88 | LMNA (0.49) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL26836499 | 0.86 | UGT2B7 (0.38) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL26834967 | 0.85 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1CKMT2A | |
| SCHEMBL26834387 | 0.85 | LMNA (0.42) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL26836502 | 0.85 | UGT2B7 (0.41) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL26781442 | 0.84 | LMNA (0.45) | LMNATRPA1PTGS1CACNA1CKMT2A | |
| SCHEMBL26834402 | 0.84 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1CUGT2B7 | |
| SCHEMBL25494030 | 0.83 | CYP2A6 (0.41) | ACHEBCHEKMT2APOLBMAPT | |
| SCHEMBL25518372 | 0.80 | ACHE (0.38) | LMNAACHEBCHEKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382935-A1 | COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE | BEIJING GREEN GUARDEE TECHNOLOGY CO., LTD. (CN) | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382935-A1 | COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE | TLK1, TLK2, PDK3 | LMNA 2429/4885TRPA1 422/4885PTGS1 3854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.